Neurological Complications of PCR-Proven M. pneumoniae Infections in Children: Prodromal Illness Duration May Reflect Pathogenetic Mechanism
|
|
- Grace Reeves
- 6 years ago
- Views:
Transcription
1 MAJOR ARTICLE Neurological Complications of PCR-Proven M. pneumoniae Infections in Children: Prodromal Illness Duration May Reflect Pathogenetic Mechanism Samiah A. Al-Zaidy, 1,2 Daune MacGregor, 3 Sanjay Mahant, 4 Susan E. Richardson, 5 and Ari Bitnun 6 1 Department of Pediatrics and Neurology, Nationwide Children s Hospital and The Ohio State University, and 2 Center for Gene Therapy, Research Institute at Nationwide Children s Hospital, Columbus, Ohio; 3 Division of Neurology, 4 Division of Paediatric Medicine, Department of Paediatrics, 5 Division of Microbiology, Department of Paediatric Laboratory Medicine, and 6 Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Canada Background. The spectrum of neurologic disease attributable to Mycoplasma pneumoniae in children is incompletely understood in part because of limitations of microbiologic diagnostic methods. Our objective was to characterize the neurologic complications of M. pneumoniae in children using stringent diagnostic criteria. Methods. All children admitted to the Hospital for Sick Children over a 16-year period with acute neurologic manifestations and polymerase chain reaction (PCR) confirmed M. pneumoniae infection were eligible for inclusion. Cases were categorized as definite, probable, or possible according to strength of evidence implicating M. pneumoniae. Children with underlying noninfectious neurologic conditions or an alternative infectious cause were excluded. Results. A total of 365 children had M. pneumoniae detected in the cerebrospinal fluid (CSF) or respiratory tract by PCR, 42 (11.5%) of whom had neurologic disease attributable to M. pneumoniae. The most common clinical syndromes were encephalitis (52%), acute disseminated encephalomyelitis (12%), transverse myelitis (12%), and cerebellar ataxia (10%). Two distinct disease patterns were observed, one with a prolonged prodrome ( 7 days), respiratory manifestations, an immunoglobulin M (IgM) response in peripheral blood, and detection of M. pneumoniae in the respiratory tract, but not the CSF, and one with a brief (<7 days) or no prodrome, less frequent respiratory manifestations and IgM response, and detection of M. pneumoniae in the CSF, but not the respiratory tract. Conclusions. Our findings support the hypothesis of two separate pathogenetic mechanisms for M. pneumoniae associated neurologic disease, one related to direct infection of the central nervous system and one indirect, likely immunologically mediated. Keywords. Mycoplasma pneumoniae; encephalitis; encephalopathy; PCR; CSF. TheroleofMycoplasma pneumoniae in causing encephalitis and other disorders of the central nervous system (CNS) remains controversial. This is principally Received 26 February 2015; accepted 9 June 2015; electronically published 17 June Correspondence: Ari Bitnun, MD, MSc, Department of Pediatrics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8 (ari. bitnun@sickkids.ca). Clinical Infectious Diseases 2015;61(7): The Author Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please journals.permissions@oup.com. DOI: /cid/civ473 due to incomplete understanding of the pathogenesis of M. pneumoniae associated CNS disease and technical and interpretive limitations of currently available microbiologic diagnostic methods [1]. While direct infection of the CNS has been implicated in a minority of cases, immune-mediated mechanisms, which are incompletely understood, appear to predominate in the majority [1 4]. Most reports in the literature have relied solely on serology for the diagnosis of M. pneumoniae associated CNS disease [5 7], despite the limited specificity of most assays [1, 8 10]. In a previous review, we demonstrated 1092 CID 2015:61 (1 October) Al-Zaidy et al
2 that 30/38 children with encephalitis who had reactive M. pneumoniae specific immunoglobulin M (IgM), but with no detectable M. pneumoniae DNA in the cerebrospinal fluid (CSF) or respiratory tract, had compelling evidence implicating other pathogens as the cause of disease [1, 11]. Further, in isolation, detection of DNA in the respiratory tract can be difficult to interpret, as asymptomatic colonization rates of 5% 13.5% have been observed during periods of increased M. pneumoniae activity [12]. In the context of respiratory illness, the genetic material of the organism can be detected for a median of 7 weeks and for as long as several months after acute infection in some patients [12 14]. Our objectives in this study were to determine more precisely the incidence and spectrum of neurologic disease attributable to acute M. pneumoniae infection in children and to ascertain whether their clinical features were consistent with distinct pathogenic mechanisms depending on the presence and duration of a nonneurologic prodromal illness as suggested by Narita [2]. To do so, we used stringent diagnostic criteria that required both detection of the organism by polymerase chain reaction (PCR) in the CSF or respiratory tract and the absence of an alternative etiologic explanation and, for the most robust cases, serologic evidence of acute infection. METHODS Patients All previously healthy patients aged 1 month to 18 years who presented to the Hospital for Sick Children (SickKids; Toronto, Canada) over a 16-year, 1-month period (1 December 1996 to 31 December 2013) with neurologic symptoms associated with detection of M. pneumoniae in respiratory tract or CSF samples by PCR were eligible for inclusion. Cases were identified through the SickKids Encephalitis Registry and Microbiology Laboratory databases. Children with neurologic symptoms attributable to a preexisting neurologic disorder were excluded. The SickKids Research Ethics Board approved the study. Clinical Diagnostic Criteria Encephalitis was defined by the presence of encephalopathy (depressed/altered level of consciousness, including lethargy, extreme irritability, or a significant change in personality) persisting for 24hoursand2ormoreofthefollowing:fever ( 38 C), seizure(s), focal neurologic findings, CSF pleocytosis (white blood cell count > /L), suggestive electroencephalographic findings, or compatible neuroimaging abnormalities [4, 11]. Isolated encephalopathy was reserved for those with fewer than 2 of the above-mentioned secondary criteria. Acute disseminated encephalomyelitis (ADEM), transverse myelitis (TM), and other conditions were defined according to standard clinical and neuroimaging findings. The study team agreed on the final diagnosis for each case after a thorough review of the patient record. Microbiological Methods and Classification of M. pneumoniae associated Neurologic Disease Detection of M. pneumoniae in respiratory tract samples and CSFwasperformedusinganin-housePCRassaywithP1 1 and P1 3 primers for the P1 adhesion gene as previously described [11, 15]. Mycoplasma pneumoniae serology was performed on acute serum and, where available, convalescent serum using a qualitative M. pneumoniae specific IgM enzyme immunoassay (GenBio, San Diego, California, ; Platelia, Bio-Rad Laboratories, Montreal, Canada, ; Trinity Biotech, Somagen, Edmonton, Canada, ). The Encephalitis Registry microbiologic workup for pathogens other than M. pneumoniae has modified over time, but its key elements have been preserved and previously described [11, 16]. This workup is performed for all children fulfilling Encephalitis Registry criteria and, although not mandated by protocol, for the majority of children admitted with ADEM, TM, and other neurologic conditions potentially associated with infection. Definite M. pneumoniae CNS disease was defined by detection of the organism in the CSF plus serologic evidence of acute infection and the absence of convincing evidence for an alternative cause. Probable M. pneumoniae CNS disease was defined by the detection of the organism in the respiratory tract by PCR plus serologic evidence of acute infection and the absence of convincing evidence for an alternative cause. Possible M. pneumoniae CNS disease was reserved for those in whom the organism was detected in the CSF or respiratory tract by PCR without serologic support for acute infection (negative or not done) and the absence of convincing evidence for an alternative cause. Convincing evidence for alternative causes included either detection of the organism by culture, PCR, or other direct detection techniques in clinical specimens or serologic evidence of acute infection such as presence of IgM in acute sera or seroconversion over a 3- to 6-week period. Statistical Analyses Statistical analyses were performed using SAS statistical software, version 9.3 (SAS Inc., Cary, North Carolina). Medians and proportions were used to describe continuous and categorical variables, respectively. With the goal of evaluating for potentially different pathogenetic groups, comparison was made between those who had prodrome symptom onset 7 days prior to development of neurologic symptoms ( prolonged prodrome) and those who had no prodrome or prodromal symptom onset <7 days prior (brief prodrome). These comparisons were done using the Kruskal Wallis test for continuous variables and the Mantel Haenszel χ 2 or Fischer exact test (as appropriate) for categorical variables. M. pneumoniae Associated Neurological Diseases CID 2015:61 (1 October) 1093
3 RESULTS Patients A total of 365 children had M. pneumoniae detected in the CSF or respiratory tract by means of PCR. Of these, 58 (15.9%) had acute neurologic symptoms. Eight were excluded on the basis of a preexisting neurologic disorder that explained their clinical presentation (complex 1 deficiency [n = 2], systemic lupus erythematosis [n = 2], seizure disorder [n = 2], hypoxic-ischemic injury [n = 1], and undiagnosed movement disorder presenting with an exacerbation of choreiform movements [n = 1]). Of the remaining 50, 8 were excluded due to identification of an alternative infectious cause (Table 1). Forty-two of the 365 children had M. pneumoniae attributable CNS disease (11.5%). Their median age was 11 years (interquartile range [IQR], 7, 13 years); 5 were <5 years of age. Fifty percent were male. There were up to 6 cases per annum, with peaks of infection and concomitant CNS-attributable disease every 2 5 years (Figure 1). According to the preset diagnostic criteria, M. pneumoniae was implicated as the definite, probable, or possible cause of CNS disease in 4, 23, and 15 cases, respectively (Table 2). The most common clinical syndrome was encephalitis (n = 22), followed by ADEM (n = 5), TM (n = 5), cerebellitis (n = 4), isolated encephalopathy (n = 2), Guillain-Barré syndrome (GBS; n = 2), cerebellar infarcts (n = 1), and meningitis (n = 1). With the exception of 1 child with cerebellitis who had leukemia, none of the 42 children had immunocompromising conditions. Table 1. Children Excluded Due to Probable Alternative Infectious Cause (n = 8) Pathogen Streptococcus pneumoniae Mycobacterium tuberculosis Herpes simplex virus-1 Herpes simplex virus-2 Epstein-Barr virus Influenza A Adenovirus Varicella zoster virus Evidence Detected in blood culture Detected in culture of sputum and in CSF by Amplified Mycobacterium tuberculosis Direct test a Detected by PCR in CSF Detected by PCR in CSF Detected by PCR in CSF; Monospot and immunoglobulin M viral capsid antigen reactive in acute sera Detected in nasopharynx by direct immunofluoresence microscopy; complement fixation titer rise from 1:8 to 1:512 b Detected in nasopharynx by direct immunofluoresence microscopy and in stool by electron microscopy Concurrent clinical chickenpox Abbreviations: CSF, cerebrospinal fluid; PCR, polymerase chain reaction. a Manufactured by Hologic, Inc., Danbury, Connecticut. b Titer change from acute to convalescent sera. Figure 1. Mycoplasma pneumoniae polymerase chain reaction positive cases by year of presentation. Abbreviation: CNS, central nervous system. Microbiologic Findings Mycoplasma pneumoniae was detected in the CSF of 40% (14/35) and in the respiratory tract of 73% (29/40) of children with M. pneumoniae attributable CNS disease (Table 3). In 1 child with TM, the organism was detected in both sites. A reactive M. pneumoniae IgM was demonstrated in 68% (27/40) of acute sera and 52% (11/21) of convalescent sera tested. All 11 children with reactive IgM in convalescent serum also had reactive IgM in acute serum. Among the 32 children who had CSF PCR, respiratory tract PCR, and acute IgM performed, a significantly higher proportion of those in whom the organism was detected only in the respiratory tract (vs only in the CSF) had a reactive IgM in blood (86% vs 18%; P <.001). In addition, convalescent M. pneumoniae serology remained negative in all 7 children tested who had M. pneumoniae detected in the CSF and a negative IgM in acute serum. Table 2. Mycoplasma pneumoniae Associated Neurological Syndromes(n=42) Mycoplasma pneumoniae Category a Syndrome Definite Probable Possible Encephalitis Transverse myelitis Acute disseminated encephalomyelitis Cerebellitis Guillain-Barré syndrome Encephalopathy Cerebellar infarct Meningitis a Definite = M. pneumoniae in cerebrospinal fluid (CSF) and immunoglobulin M (IgM) in peripheral blood; probable = M. pneumoniae in respiratory tract and IgM in peripheral blood; possible = M. pneumoniae detected in CSF or respiratory tract, but no documented IgM response in peripheral blood CID 2015:61 (1 October) Al-Zaidy et al
4 Table 3. Clinical and Microbiologic Features According to Prodrome Duration in Mycoplasma pneumoniae Associated Central Nervous System Disease (n = 42) No Prodrome Parameter or Prodrome <7 d (n = 15) Prodrome 7 d (n = 27) P Value* Syndrome NS Encephalitis 9 13 Acute disseminated 1 4 encephalomyelitis Transverse myelitis 2 3 Other a 3 7 Respiratory tract findings Respiratory symptoms 40% (6/15) 93% (25/27) <.001 Chest radiograph abnormalities 33% (3/9) 75% (15/20).05 M. pneumoniae testing results Respiratory tract PCR+ 38% (5/13) 89% (24/27).002 CSF PCR+ 79% (11/14) 14% (3/21) <.001 IgM in acute sera 23% (3/13) 89% (24/27) <.001 IgM in convalescent sera 20% (2/10) 82% (9/11).009 A separate analysis according to site of detection of M. pneumoniae showed that CSF PCR-positive patients (n = 14) were less likely to have a respiratory prodrome (43% vs 90%; P =.006), lobar infiltrate on chest X ray (10% vs 67%; P =.01), or IgM in acute serum (31% vs 86%; P =.002) than CSF PCRnegative patients (n = 21); all 5 children <5 years of age had M. pneumoniae detected by PCR in CSF; none of the children who had M. pneumoniae detected by PCR in CSF had a documented immune deficiency. Abbreviations: CSF, cerebrospinal fluid; IgM, immunoglobulin M; NS, not significant; PCR, polymerase chain reaction. a Included cerebellar disease (n = 5), isolated encephalopathy (n = 2), Guillain- Barré syndrome (n = 2), and meningitis (n = 1). * Mantel Haenszel χ 2 or Fischer exact test as appropriate. Clinical Features A prodromal illness was reported in 90% (38/42) of children andincludedfeverin74%,respiratorysymptoms(mostly cough) in 74%, or gastrointestinal symptoms (mostly vomiting) in 12%. Those with a prolonged prodrome were more likely than those with a brief prodrome to have had respiratory symptoms, chest radiograph abnormalities, detection of M. pneumoniae in the respiratory tract, but not the CSF, and to have had a reactive IgM in acute serum (Table 3). All 23 children who had M. pneumoniae detected in the respiratory tract and a reactive IgM in serum had a prodromal illness of 7 days. There were 22 children with encephalitis. Their median age was 11 years (IQR, 7, 13 years) with only 2 being <5 years of age. Fifty-four percent were male. Fever was the most common symptom at the time of admission (86%) other than encephalopathy, present by definition in all cases. Headache was observed in 59%, seizures in 50%, and focal neurologic deficits in 27%. Nine required intensive care unit admission. A lymphocytic pleocytosis (> /L) and elevated CSF protein ( 0.4 g/l) were observed in 64% and 50%, respectively. Electroencephalographic abnormalities, demonstrated in 14/15 tested, consisted predominantly of generalized (60%) or focal (33%) slowing. Of the 19 patients who had magnetic resonance imaging (MRI) performed, 74% had abnormalities, the most common of which consisted of increased signal intensity in subcortical structures (thalami, basal ganglia, pons, or brainstem; 47%). Compared with those with a brief prodrome, those with a prolonged prodrome were more likely to have had respiratory symptoms, abnormal CSF profile, and to have MRI changes affecting subcortical structures (Table 4). All but 1 of the 9 children with subcortical neuroimaging findings were 7 years of age and 89% (8/9) of them had a respiratory prodrome that preceded neurologic symptom onset by 7 days. ADEM and TM were the most common nonencephalitis disorders attributable to M. pneumoniae (n = 10). The median age of these patients was 10.5 years (IQR, 9.9, 13.0 years); none were <7 years of age. The sex distribution was equal. All but 1 had a documented respiratory prodrome a median of 14 days prior to neurologic symptom onset (IQR, 6, 30 days). In those with ADEM, all 5 had headache and vomiting, 4 were febrile, 4 had focal neurologic deficits, 2 had encephalopathy, and 1 had seizures. All 5 children with TM had focal neurologic deficits, 2 had headache, and 1 was febrile. All 10 had pleocytosis (median /L;IQR,7, /L) and50%hadelevatedcsfprotein(median,0.48g/l;iqr, 0.32, 1.1 g/l). Treatment and Outcome Twenty-nine children, including 19 with encephalitis, 6 with ADEM or TM, and 4 with other conditions were treated with a 7- to 14-day course of a macrolide (erythromycin, clarithromycin, or azithromycin) or a fluoroquinolone (ciprofloxacin or levofloxacin) antibiotic. A short course of corticosteroid treatment was given to 17 children, including 7 with encephalitis, 5 with TM, 4 with ADEM, and 1 with cerebellitis. Fifteen of those treated with antibiotics (52%) and 9 of those treated with corticosteroids (53%) had an adverse neurologic outcome. Among children with encephalitis, 53% of the 19 who received antibiotics suffered neurologic sequelae. An adverse outcome was observed in 71% (5/7) of children with encephalitis who received corticosteroids vs 40% (6/15) of those who did not (P =.4). This apparent lack of benefit held true for the encephalitis subgroups by prodromal length. Follow-up data were available for all but 3 patients, with a median follow-up duration of 1.2 years after discharge (IQR, 0.3, 4.0 years). There were no deaths. Adverse neurologic outcome was observed in 20 (48.8%) children including 11 with encephalitis, 2 with ADEM, 1 with TM, 1 with encephalopathy, 2 M. pneumoniae Associated Neurological Diseases CID 2015:61 (1 October) 1095
5 Table 4. Clinical Features According to Prodrome Duration in Mycoplasma pneumoniae Encephalitis (n = 22) Clinical Feature Encephalitis With no Prodrome or Prodrome <7 d (n = 9) Encephalitis With Prodrome 7 d (n = 13) P Value* Age (y) a 13 (9, 15) 11 (7, 11).09 Sex (% female) 44% (5/9) 62% (8/13) NS Prodromal symptoms Fever 78% (7/9) 92% (12/13) NS Cough/corza/sore throat 33% (3/9) 85% (11/13).03 Vomiting/diarrhea 33% (3/9) 77% (10/13).08 Neurologic symptoms Seizures 67% (6/9) 38% (5/13) NS Focal deficits 22% (2/9) 31% (4/13) NS Headache 56% (5/9) 62% (8/13) NS Chest X-ray findings 33% (2/6) 77% (10/13).1 Interstitial 0% (0/6) 8% (1/13) NS Lobar 17% (1/6) 54% (7/13).2 CSF findings Any abnormality 44% (4/9) 85% (11/13).07 White blood cell count (cells/mm 3 ) a 2 (2, 19) 54 (17, 148).04 Protein (g/l) a 0.30 (0.17, 0.30) 0.57 (0.45, 0.84).004 M. pneumoniae detection Respiratory tract PCR+ 38% (3/8) 92% (12/13).01 CSF PCR+ 75% (6/8) 10% (1/10).01 IgM in acute serum 13% (1/8) 92% (12/13) <.001 IgM in convalescent serum 13% (1/8) 88% (7/8).01 Electroencephalogram abnormalities 75% (6/8) 100% (7/7) NS Generalized slowing 63% (5/8) 57% (4/7) NS Focal slowing 25% (2/8) 43% (3/7) NS Epileptiform 13% (1/8) 0% (0/7) NS Magnetic resonance imaging abnormalities b 50% (4/8) 91% (10/11).1 Cortical 38% (3/8) 27% (3/11) NS Subcortical c 13% (1/8) 73% (8/11).02 Cerebellum 0% (0/8) 27% (3/11).2 Treatment Macrolide/fluoroquinolone 67% (6/9) 100% (13/13).05 Corticosteroids 33% (3/9) 31% (4/13) NS Outcome Normal 44% (4/9) 62% (8/13) NS Epilepsy 56% (5/9) 8% (1/13).02 Focal deficits 0% (0/9) 31% (4/13).1 Abbreviations: CSF, cerebrospinal fluid; IgM, immunoglobulin M; MRI, magnetic resonance imaging; NS, not significant; PCR, polymerase chain reaction. a Results displayed as median (interquartile range). b All 3 children who did not have an MRI performed had normal computed tomography scans of the brain. c Subcortical refers to basal ganglia, thalamus, pons, and brainstem. * χ 2 for proportions (Fischer exact test); Kruskal Wallis test for continuous variables. with GBS, and 2 with cerebellar disease. In children with encephalitis, neurologic sequelae included epilepsy (27%; n = 6), focal neurologic deficits (18%; n = 4), and persistent headache (5%; n = 1). Neurologic sequelae in those with conditions other than encephalitis included focal neurologic deficits (32%; n = 6), behavioral problems (11%; n = 2), and persistent headaches (5%; n = 1). There was no significant statistical correlation between adverse outcome and duration of prodromal illness, seizures, focal neurologic deficits, CSF findings, neuroimaging abnormalities, site of detection of the organism, or IgM in acute serum in the cohort as a whole. Among encephalitis patients, epilepsy was more common in those in the brief 1096 CID 2015:61 (1 October) Al-Zaidy et al
6 prodrome category, whereas residual focal deficits were seen only in those in the prolonged prodrome category (Table 4). DISCUSSION Neurologic complications occurred in 11.5% of children hospitalized in our institution with PCR-confirmed M. pneumoniae infection. However, the true rate of M. pneumoniae associated neurologic complications among hospitalized children with M. pneumoniae infection is likely substantially lower, as testing for M. pneumoniae in our institution is not routine for those with pneumonia or other respiratory illnesses but is routine for encephalitis and other neurologic diseases. We believe the 10% incidence of CNS disease observed among Finish children with a 4-fold rise in complement fixation titer to M. pneumoniae [6] was likely also a significant overestimate, related to selective testing, as in our institution, but also to the limited specificity of the complement fixation test [8]. The full spectrum of M. pneumoniae associated neurologic disease in children has not been studied in detail. In a retrospective review spanning a 24-year period in Finland, all 45 children with serologically confirmed M. pneumoniae neurologic disease had encephalitis [5]. Because the comprehensive investigation afforded by our encephalitis registry is applied routinely to children with suspected ADEM, TM, and other serious neurologic disorders (in addition to encephalitis) and because of our stringent diagnostic criteria for M. pneumoniae associated neurologic disease, we believe that our study provides a more precise description of M. pneumoniae associated neurologic disease spectrum in children. Encephalitis was the most common disorder (52%), followed by ADEM (12%), TM (12%), and cerebellitis (10%). The relative rarity of meningitis is difficult to interpret, as M. pneumoniae testing was not routinely done in children who presented with a clinical picture of aseptic meningitis as this is generally a benign self-resolving condition. For the same reason, it is possible that mild forms of M. pneumoniae cerebellar ataxia went undiagnosed. The most intriguing observations of our study were that M. pneumoniae was detected by PCR in either the respiratory tract or the CSF, but not both (with 1 exception), and that there were 2 distinct disease patterns, 1 associated with a prolonged prodrome ( 7 days)and 1 associated with a shorter (<7 days) or absent prodrome prior to development of neurologic symptoms. Those with the prolonged prodrome had higher rates of respiratory symptoms, chest radiograph abnormalities, IgM response in peripheral blood, and detection of M. pneumoniae in the respiratory tract. The association of a brief prodrome with detection of M. pneumoniae in the CSF, but not the respiratory tract, and the lack of an IgM response in peripheral blood suggest rapid spread to the CNS prior to significant organism replication in the respiratory tract. The lack of IgM response in those with a brief prodrome is not likely a reflection of early sampling, as all 8 children with a short or no prodrome and nonreactive IgM in acute serum who had a convalescent sample tested remained IgM negative. An indirect pathogenetic mechanism appears more likely for those with a prolonged prodrome exhibiting robust respiratory inflammation as evidenced by higher rates of respiratory symptoms and chest radiograph abnormalities, the development of an IgM response in peripheral blood, and detection of the organism only in the respiratory tract. Taken together, these findings support the hypothesis of 2 distinct neurologic disease forms, 1 of early onset associated with direct infection of the CNS and 1 of late onset mediated by indirect, likely immunologically mediated, mechanisms [2, 17]. It is noteworthy that there was no discernible difference in clinical syndrome according to prodrome duration despite the apparent association of the latter with differing pathogenetic mechanisms. It is possible that a given clinical phenotype could be caused by several different pathogenetic mechanisms. Other factors that could be at play are a lack of precision of prodrome duration in the medical record due to recall bias on the part of the child and caregiver or inadequate statistical power to associate pathogenetic mechanism with clinical phenotype, given the small number of cases overall. The potential benefit of antibiotic and corticosteroid therapy in M. pneumoniae associated neurologic disease cannot be inferred from our cohort primarily because of inherent biases related to nonrandom selection of patients for treatment. In those with encephalitis there did not appear to be any clear benefitto antibiotic therapy, as 53% of the 19 treated children nevertheless suffered neurologic sequelae. With regard to corticosteroids, only 29% (2/7) of children with encephalitis in our cohort who received corticosteroids fully recovered. This contrasts with a previously published case report and literature review that noted complete or near-complete recovery in 78% (11/14) of corticosteroid-treated patients with serologically confirmed M. pneumoniae encephalitis [18]. This discrepancy may, in part, be related to the severity of disease in those selected for treatment in our cohort or to the lack of comparability between the published cohort and ours due to the very different selection criteria. In addition, in the aforementioned literature review, an overly optimistic finding may have resulted from publication bias. For children with ADEM, TM, or GBS, the preponderance of evidence in the literature supports the utility of immunemodulating therapies such as corticosteroids, intravenous immunoglobulin and/or plasmapheresis [3, 4]. Therationaleforrestrictingourinclusioncriteriatothose without convincing evidence of infection with other pathogens was to enhance the validity of our findings with respect to M. pneumoniae as a cause of neurologic disease. However, it is possible that M. pneumoniae coinfection contributed to neurologic disease in some of the children excluded on the basis of an M. pneumoniae Associated Neurological Diseases CID 2015:61 (1 October) 1097
7 alternative infectious etiology [11]. False-positive PCR for M. pneumoniae is unlikely, given our routine use of appropriate positive and negative controls. In conclusion, this is one of the largest and most rigorously defined studies of M. pneumoniae neurologic disease in children. It suggests that M. pneumoniae associated neurologic complications comprise up to 11.5% of hospitalizations due to this pathogen. Encephalitis is the most common syndrome followed by ADEM, TM, and cerebellar ataxia. The clear association of prodrome duration with site of detection of the organism, extent of respiratory illness, as and IgM response in peripheral blood strongly supports the hypothesis of 2 separate pathogenetic mechanisms of disease. Future research should focus on bettering our understanding of pathogenesis so that more targeted and rationale therapeutic interventions can be instituted. Notes Acknowledgments. We sincerely thank Suganya Lee for her role as the Encephalitis Registry research nurse. Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. References 1. Bitnun A, Richardson SE. Mycoplasma pneumoniae: innocent bystander or a true cause of central nervous system disease? Curr Infect Dis Rep 2010; 12: Narita M. Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection. Pediatr Neurol 2009; 41: Tsiodras S, Kelesidis I, Kelesidis T, Stamboulis E, Giamarellou H. Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect 2005; 51: Bitnun A, Richardson S. Mycoplasmal and ureaplasmal infections. In: Scheld WM, Whitley RJ, Marra CM, eds. Infections of the central nervous system. Philadelphia: Wolters Kluwer, 2014: Koskiniemi M. CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review. Clin Infect Dis 1993; 17(suppl 1):S Ponka A. Central nervous system manifestations associated with serologically verified Mycoplasma pneumoniae infection. Scand J Infect Dis 1980; 12: Lehtokoski-Lehtiniemi E, Koskiniemi ML. Mycoplasma pneumoniae encephalitis: a severe entity in children. Pediatr Infect Dis J 1989; 8: Kenny GE, Kaiser GG, Cooney MK, Foy HM. Diagnosis of Mycoplasma pneumoniae pneumonia: sensitivities and specificities of serology with lipid antigen and isolation of the organism on soy peptone medium for identification of infections. J Clin Microbiol 1990; 28: Leinikki PO, Panzar P, Tykka H. Immunoglobulin M antibody response against Mycoplasma pneumoniae lipid antigen in patients with acute pancreatitis. J Clin Microbiol 1978; 8: Kleemola M, Kayhty H. Increase in titers of antibodies to Mycoplasma pneumoniae in patients with purulent meningitis. J Infect Dis 1982; 146: Bitnun A, Ford-Jones EL, Petric M, et al. Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis 2001; 32: Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 1993; 17(suppl 1):S Nilsson AC, Bjorkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol 2008; 8: Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis 2009; 48: Ursi JP, Ursi D, Ieven M, Pattyn SR. Utility of an internal control for the polymerase chain reaction. Application to detection of Mycoplasma pneumoniae in clinical specimens. APMIS 1992; 100: Kolski H, Ford-Jones EL, Richardson S, et al. Etiology of acute childhood encephalitis at the Hospital for Sick Children, Toronto, Clin Infect Dis 1998; 26: Narita M, Itakura O, Matsuzono Y, Togashi T. Analysis of mycoplasmal central nervous system involvement by polymerase chain reaction. Pediatr Infect Dis J 1995; 14: Carpenter TC. Corticosteroids in the treatment of severe mycoplasma encephalitis in children. Crit Care Med 2002; 30: CID 2015:61 (1 October) Al-Zaidy et al
Mycoplasma pneumoniae % loop-mediated isothermal amplification LAMP DNA
50 2018 50 50 4 8 1,2 1,2 1 1 1 1 1 1 1 1 2010 2016 0 15 8 6 2 2 14 3 2 10 6 MERS 2 3 1 Bickerstaff 1 1 6 MERS 1 1 loop-mediated isothermal amplification DNA Mycoplasma pneumoniae 1 1 10% 2 3 4 6 8 2010
More informationCOPYRIGHT 2012 THE TRANSVERSE MYELITIS ASSOCIATION. ALL RIGHTS RESERVED
The Transverse Myelitis Association...advocating for those with acute disseminated encephalomyelitis, neuromyelitis optica, optic neuritis and transverse myelitis ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM)
More informationRole of MRI in acute disseminated encephalomyelitis
Original Research Article Role of MRI in acute disseminated encephalomyelitis Shashvat Modiya 1*, Jayesh Shah 2, C. Raychaudhuri 3 1 1 st year resident, 2 Associate Professor, 3 HOD and Professor Department
More informationClinical Information on West Nile Virus (WNV) Infection
Clinical Information on West Nile Virus (WNV) Infection Introduction In 1999, West Nile Virus (WNV), an Old World flavivirus, producing a spectrum of disease including severe meningoencephalitis, appeared
More informationDisclosures. Objectives. Epidemiology. Enterovirus 68. Enterovirus species 9/24/2015. Enterovirus D68: Lessons Learned from the Frontline
Enterovirus D68: Lessons Learned from the Frontline Disclosures Jennifer Schuster, MD MSCI Children s Mercy Hospital Pediatric Infectious Diseases September 16, 2015 I have nothing to disclose I do not
More informationS (18) doi: /j.ensci Reference: ENSCI 122
Accepted Manuscript A case of cerebellar ataxia associated with VZV infection Hirofumi Matsuyama, Takekazu Ohi PII: S2405-6502(18)30012-1 DOI: doi:10.1016/j.ensci.2018.04.003 Reference: ENSCI 122 To appear
More informationPediatric acute demyelinating encephalomyelitis in Denmark: a nationwide population-based study
Pediatric acute demyelinating encephalomyelitis in Denmark: a nationwide population-based study Magnus Spangsberg Boesen November, 2016 Supervisors: P. Born, P. Uldall, M. Blinkenberg, M. Magyari, F. Sellebjerg
More informationComparison of Laboratory Diagnostic Procedures for Detection of Mycoplasma pneumoniae in Community Outbreaks
MAJOR ARTICLE Comparison of Laboratory Diagnostic Procedures for Detection of Mycoplasma pneumoniae in Community Outbreaks Kathleen A. Thurman, 1 Nicholas D. Walter, 1,2 Stephanie B. Schwartz, 1 Stephanie
More informationAppendix B: Provincial Case Definitions for Reportable Diseases
Ministry of Health and Long-Term Care Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: West Nile Virus Illness Revised March 2017 West Nile Virus Illness
More informationAcute Childhood Encephalitis and Mycoplasma pneumoniae
MAJOR ARTICLE Acute Childhood Encephalitis and Mycoplasma pneumoniae Ari Bitnun, 1 Elizabeth Lee Ford-Jones, 1 Martin Petric, 3 Daune MacGregor, 2 Helen Heurter, 1 Susan Nelson, 4 Grant Johnson, 3 and
More informationAppendix B: Provincial Case Definitions for Reportable Diseases
Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: Influenza Revised December 2014 Influenza 1.0 Provincial Reporting Confirmed cases of disease 2.0 Type
More informationAppendix I (a) Human Surveillance Case Definition (Revised July 4, 2005)
Section A: Case Definitions Appendix I (a) Human Surveillance Case Definition (Revised July 4, 2005) The current Case Definitions were drafted with available information at the time of writing. Case Definitions
More informationMANAGEMENT OF SUSPECTED VIRAL ENCEPHALITIS IN CHILDREN
MANAGEMENT OF SUSPECTED VIRAL ENCEPHALITIS IN CHILDREN OVERVIEW 1980s: dramatically improved by aciclovir HSV encephalitis in adults Delays treatment(> 48h after hospital admission): associated with a
More informationAntimicrobial Stewardship in Community Acquired Pneumonia
Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis
More informationPCR Is Not Always the Answer
PCR Is Not Always the Answer Nicholas M. Moore, PhD(c), MS, MLS(ASCP) CM Assistant Director, Division of Clinical Microbiology Assistant Professor Rush University Medical Center Disclosures Contracted
More informationThe Neurology of HIV Infection. Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University
The Neurology of HIV Infection Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University HIV/AIDS Epidemiology World-wide pandemic, 40 million affected U.S.- Disproportionate
More informationSHASTA COUNTY Health and Human Services Agency
FROM: 530 229 8447 TO: 15302293984 08/06/14 12:30 Pg 1 of 5 especially SHASTA COUNTY Health and Human Services Agency Public Health 2650RreslauerWay Redding, CA 96001-4297 (530) 229-8484 FAX (530) 225-3743
More informationCase Classification West Nile Virus Neurological Syndrome (WNNS)
WEST NILE VIRUS Case definition Case Classification West Nile Virus Neurological Syndrome (WNNS) CONFIRMED CASE West Nile Virus Neurological Syndrome (WNNS) Clinical criteria AND at least one of the confirmed
More informationLong-Term Outcomes and Risk Factors Associated With Acute Encephalitis in Children
Journal of the Pediatric Infectious Diseases Society ORIGINAL ARTICLE Long-Term Outcomes and Risk Factors Associated With Acute Encephalitis in Children Suchitra Rao, 1,2 Benjamin Elkon, 2 Kelly B. Flett,
More informationPrognostic indicators of childhood acute viral encephalitis
ecommons@aku Community Health Sciences Department of Community Health Sciences December 1999 Prognostic indicators of childhood acute viral encephalitis E Bhutto Aga Khan University M Naim Aga Khan University
More informationMycoplasma pneumoniae IgG ELISA Kit
Mycoplasma pneumoniae IgG ELISA Kit Catalog Number KA2260 96 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle
More informationPCR Is Not Always the Answer
PCR Is Not Always the Answer Nicholas M. Moore, PhD, MS, MLS(ASCP) CM Assistant Director, Division of Clinical Microbiology Assistant Professor Rush University Medical Center Disclosures Contracted research:
More informationDENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT
DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT Usa Thisyakorn and Chule Thisyakorn Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Abstract. Dengue has spread
More informationShould a hospitalized child receive empiric treatment with acyclovir?
Kulik et al. Italian Journal of Pediatrics 2012, 38:72 ITALIAN JOURNAL OF PEDIATRICS RESEARCH Should a hospitalized child receive empiric treatment with acyclovir? Dina M Kulik 3, Magda Mekky 1, Ming Yang
More informationSupplementary Online Content
Supplementary Online Content Van Haren K, Ayscue P, Waubant E, et al. Acute flaccid myelitis of unknown etiology in California, 2012-2015. JAMA. doi:10.1001/jama.2015.17275 emethods eresults efigure 1.
More informationBeyond the Reflex Arc: An Evidence-Based Discussion of the Management of Febrile Infants
Beyond the Reflex Arc: An Evidence-Based Discussion of the Management of Febrile Infants Cole Condra, MD MSc Division of Emergency Medical Services Children s Mercy Hospital October 1, 2011 Disclosure
More informationالحترمونا من خري الدعاء
الحترمونا من خري الدعاء Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could be true or
More informationEncephalitis following Purified Chick-Embryo Cell Anti-Rabies Vaccination
CASE REPORT JIACM 2003; 4(3): 251-9 Encephalitis following Purified Chick-Embryo Cell Anti-Rabies Vaccination NS Neki*, Ashok Khurana**, Ashok Duggal*** Abstract A case of encephalitis following purified
More informationClinical Features of Mycoplasmal Pneumonia in Adults
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 56 (1983), 505-510 Clinical Features of Mycoplasmal Pneumonia in Adults KINICHI IZUMIKAWA, M.D., AND KOHEI HARA, M.D. Second Department of Internal Medicine, Nagasaki
More informationANTIBODIES TO HERPES-SIMPLEX VIRUS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH HER- PETIC ENCEPHALITIS
ANTIBODIES TO HERPES-SIMPLEX VIRUS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH HER- PETIC ENCEPHALITIS F. 0. MACCALLUM, I. J. CHINN AND J. V. T. GOSTLMG Virology Laboratory, Radclife Infirmary, Oxford
More informationContents 1 Immunology for the Non-immunologist 2 Neurology for the Non-neurologist 3 Neuroimmunology for the Non-neuroimmunologist
1 Immunology for the Non-immunologist... 1 1 The Beginnings of Immunology... 1 2 The Components of the Healthy Immune Response... 2 2.1 White Blood Cells... 4 2.2 Molecules... 8 References... 13 2 Neurology
More informationHuman Herpes Viruses (HHV) Mazin Barry, MD, FRCPC, FACP, DTM&H Assistant Professor and Consultant Infectious Diseases KSU
Human Herpes Viruses (HHV) Mazin Barry, MD, FRCPC, FACP, DTM&H Assistant Professor and Consultant Infectious Diseases KSU HERPES VIRUS INFECTIONS objectives: ØTo know the clinically important HHVs. ØTo
More informationUnsupervised activity is a major risk factor for traumatic coma and its age-specific
The assessment of patients in coma is a medical emergency. The cause should be identified and, where possible, corrected and the brain provided with appropriate protection to reduce further damage. It
More informationCorporate Medical Policy
Corporate Medical Policy Identification of Microorganisms Using Nucleic Acid Probes File Name: Origination: Last CAP Review: Next CAP Review: Last Review: identification_of_microorganisms_using_nucleic_acid_probes
More informationStructure of viruses
Antiviral Drugs o Viruses are obligate intracellular parasites. o lack both a cell wall and a cell membrane. o They do not carry out metabolic processes. o Viruses use much of the host s metabolic machinery.
More informationGeneral Medical Concerns
General Medical Concerns General Medical Concerns Fred Reifsteck MD Head Team Physician University of Georgia Missed Time: school, work, practice, games Decreased Performance Physical/ Mental stress: New
More informationAseptic meningitis: inflammation of meninges with sterile CSF (without any causative organisms which can be grown on culture media).
You have to refer to the slides, since I have included the extra information only. Slide #1: Both illnesses aseptic meningitis and encephalitis can be caused by the same viruses; that viruses which cause
More informationPolio (Paralytic and Non-paralytic
Polio (Paralytic and Non-paralytic Infection) rev Jan 2018 Infectious Agent Poliovirus (genus Enterovirus) types, 1, 2, and 3. BASIC EPIDEMIOLOGY Transmission Poliovirus is transmitted by person-to-person
More informationImmunopathology of Guillain- Barré syndrome. L. Magy Service de Neurologie Centre de Référence 'Neuropathies Périphériques Rares' CHU Limoges, France
Immunopathology of Guillain- Barré syndrome L. Magy Service de Neurologie Centre de Référence 'Neuropathies Périphériques Rares' CHU Limoges, France What is Guillain-Barré syndrome? An immune-mediated
More informationFever in neonates (age 0 to 28 days)
Fever in neonates (age 0 to 28 days) INCLUSION CRITERIA Infant 28 days of life Temperature 38 C (100.4 F) by any route/parental report EXCLUSION CRITERIA Infants with RSV Febrile Infant 28 days old Ill
More informationHuman infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance
Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance 10 July 2009 Background This document updates the interim WHO guidance on global surveillance of pandemic
More informationTitle: Revision to the Standardized Surveillance and Case Definition for Acute Flaccid Myelitis
17-ID-01 Committee: Infectious Disease Title: Revision to the Standardized Surveillance and Case Definition for Acute Flaccid Myelitis I. Statement of the Problem Acute flaccid myelitis (AFM) is a syndrome
More informationClinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA
Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes
More informationChronic Lung Disease in vertically HIV infected children. Dr B O Hare Senior Lecturer in Paediatrics and Child Health, COM, Blantyre
Chronic Lung Disease in vertically HIV infected children Dr B O Hare Senior Lecturer in Paediatrics and Child Health, COM, Blantyre Natural history of HIV in vertically infected children without and with
More information- Mycoplasma pneumoniae (MP): important respiratory pathogen in children that cause many upper and lower respiratory tract diseases, including
KHOA DICH VU HO HAP - Mycoplasma pneumoniae (MP): important respiratory pathogen in children that cause many upper and lower respiratory tract diseases, including wheezing, coryza, bronchopneumonia. -
More informationTransient asymptomatic white matter lesions following Epstein-Barr virus encephalitis
Case report http://dx.doi.org/10.3345/kjp.2011.54.9.389 Korean J Pediatr 2011;54(9):389-393 Transient asymptomatic white matter lesions following Epstein-arr virus encephalitis Yoon Young Jang, MD, Kye
More informationScottish Surveillance of Healthcare Associated Infection Programme (SSHAIP) Health Protection Scotland (HPS) SSI Surveillance Protocol 7th Edition
1 Contents Female reproductive system operations (Abdominal hysterectomy and Caesarean section)... 3 Intra-abdominal infections... 3 Endometritis... 4 Other infections of the female reproductive tract...
More informationDilemmas in the Management of Meningitis & Encephalitis HEADACHE AND FEVER. What is the best initial approach for fever, headache, meningisums?
Dilemmas in the Management of Meningitis & Encephalitis Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine HEADACHE AND FEVER What is the best initial approach for fever,
More informationInfection-Associated Neurological Syndromes
Infection-Associated Neurological Syndromes Anand P, MD PhD Medical Director, BloodCenter of Wisconsin Assistant Professor, Medical College of Wisconsin ASFA Annual Meeting San Antonio, TX, May 8th, 2015
More informationCNS Infections. Philip Gothard Consultant in Infectious Diseases Hospital for Tropical Diseases, London. Hammersmith Acute Medicine 2011
CNS Infections Philip Gothard Consultant in Infectious Diseases Hospital for Tropical Diseases, London Hammersmith Acute Medicine 2011 Case 1 HISTORY 27y man Unwell 3 days Fever Headache Photophobia Previously
More informationEvaluation of the Oxoid Xpect Legionella test kit for Detection of Legionella
JCM Accepts, published online ahead of print on 6 May 2009 J. Clin. Microbiol. doi:10.1128/jcm.00397-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationNEUROLOGICAL MANIFESTATIONS IN DENGUE PATIENTS
NEUROLOGICAL MANIFESTATIONS IN DENGUE PATIENTS Chitsanu Pancharoen and Usa Thisyakorn Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Abstract. To determine the
More informationProbable etiology of mild encephalopathy with reversible isolated lesions in the corpus callosum in children: A review of 20 cases from northern China
Neurology Asia 2018; 23(2) : 153 158 Probable etiology of mild encephalopathy with reversible isolated lesions in the corpus callosum in children: A review of 20 cases from northern China Chao-Yang Li,
More informationChallenges in viral CNS infections [encephalitis]
Challenges in viral CNS infections [encephalitis] PIGS Training Course 2013 Basel November 8, 2013 Christoph Aebi christoph.aebi@insel.ch Definition Encephalitis is defined as a syndrome of neurological
More informationReporting of Severe and Fatal Pediatric Influenza New Jersey Department of Health Influenza Season
Reporting of Severe and Fatal Pediatric Influenza New Jersey Department of Health 2016-2017 Influenza Season Patients meeting the below criteria should be entered into the Communicable Disease Reporting
More informationMicrobiology Laboratory Directors, Infection Preventionists, Primary Care Providers, Emergency Department Directors, Infectious Disease Physicians
MEMORANDUM DATE: October 1, 2009 TO: FROM: SUBJECT: Microbiology Laboratory Directors, Infection Preventionists, Primary Care Providers, Emergency Department Directors, Infectious Disease Physicians Michael
More informationMagnetic Resonance Imaging Findings of Mumps Meningoencephalitis with Bilateral Hippocampal Lesions without Preceding Acute Parotitis: A Case Report
Case Report Neuroimaging and Head & Neck https://doi.org/10.3348/kjr.2017.18.2.378 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2017;18(2):378-382 Magnetic Resonance Imaging Findings of Mumps Meningoencephalitis
More informationFever in the Newborn Period
Fever in the Newborn Period 1. Definitions 1 2. Overview 1 3. History and Physical Examination 2 4. Fever in Infants Less than 3 Months Old 2 a. Table 1: Rochester criteria for low risk infants 3 5. Fever
More informationSurveillance for encephalitis in Bangladesh: preliminary results
Surveillance for encephalitis in Bangladesh: preliminary results In Asia, the epidemiology and aetiology of encephalitis remain largely unknown, particularly in Bangladesh. A prospective, hospital-based
More informationA Child with Cross Eye. Nia Kurniati
A Child with Cross Eye Nia Kurniati Background When dealing with new case with potential social problem, complication related to ARV treatment may pose difficulties Restricted resource to address potential
More informationComplete occlusion of the right middle cerebral artery associated with Mycoplasma
Complete occlusion of the right middle cerebral artery associated with Mycoplasma pneumoniae pneumonia Ben Kang, M.D. 1, Dong Hyun Kim, M.D. 2, Young Jin Hong, M.D., Ph.D. 2, Byong Kwan Son, M.D., Ph.D.
More informationInfluenza-Associated Pediatric Mortality rev Jan 2018
rev Jan 2018 Infectious Agent Influenza A, B or C virus BASIC EPIDEMIOLOGY Transmission Transmission occurs via droplet spread. After a person infected with influenza coughs, sneezes, or talks, influenza
More informationLaboratory diagnosis of congenital infections
Laboratory diagnosis of congenital infections Laboratory diagnosis of HSV Direct staining Tzanck test Immunostaining HSV isolation Serology PCR Tzanck test Cell scrape from base of the lesion smear on
More informationThe Diagnostic Accuracy of Kernig s Sign, Brudzinski s Sign, and Nuchal Rigidity in Adults with Suspected Meningitis
MAJOR ARTICLE The Diagnostic Accuracy of Kernig s Sign, Brudzinski s Sign, and Nuchal Rigidity in Adults with Suspected Meningitis Karen E. Thomas, 1 Rodrigo Hasbun, 1 James Jekel, 2 and Vincent J. Quagliarello
More informationMumps. October Susan Even MD University of Missouri-Columbia. Robert Palinkas MD University of Illinois at Urbana-Champaign
Mumps October 20 2014 Susan Even MD University of Missouri-Columbia Robert Palinkas MD University of Illinois at Urbana-Champaign Craig Roberts PA-C, MS University of Wisconsin-Madison Objectives Define
More informationFigure 1: Suspected and confirmed Zika virus cases reported by countries and territories in the Americas, by epidemiological week (EW)
Zika - Epidemiological Update 17 March 2016 Zika virus Incidence and trends Available data reported suggests a downward trend in reporting of Zika virus cases in the Region of the Americas (Figure 1).
More informationCNS Infections in the Pediatric Age Group
CNS Infections in the Pediatric Age Group Introduction CNS infections are frequently life-threatening In the Philippines, bacterial meningitis is one of the top leading causes of mortality in children
More informationSevere Acute Respiratory Syndrome ( SARS )
Severe Acute Respiratory Syndrome ( SARS ) Dr. Mohammad Rahim Kadivar Pediatrics Infections Specialist Shiraz University of Medical Sciences Slides Designer: Dr. Ramin Shafieian R. Dadrast What is SARS?
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Carrera J-P, Forrester N, Wang E, et al. Eastern equine encephalitis
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency
Quality ID #419: Overuse Of Neuroimaging For Patients With Primary Headache And A Normal Neurological Examination National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL
More informationAppendix 2 (as supplied by the authors): ICD codes to identify high-risk children
Appendix 2 (as supplied by the authors): ICD codes to identify high-risk children ICD-9 codes to identify high risk children in physician claims database Category of condition Condition ICD-9 code Bacterial
More informationESCMID Online Lecture Library. by author
INFLUENZA IN CHILDREN Cristian Launes Infectious Diseases Unit. Department of Paediatrics. Hospital Sant Joan de Déu (Universitat de Barcelona) Innovation in Severe Acute Respiratory Infections (SARI),
More informationChapter 22. Pulmonary Infections
Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired
More informationProf Dr Najlaa Fawzi
1 Prof Dr Najlaa Fawzi is an acute highly infectious disease, characterized by vesicular rash, mild fever and mild constitutional symptoms. is a local manifestation of reactivation of latent varicella
More informationUpper Respiratory Infections. Mehreen Arshad, MD Assistant Professor Pediatric Infectious Diseases Duke University
Upper Respiratory Infections Mehreen Arshad, MD Assistant Professor Pediatric Infectious Diseases Duke University Disclosures None Objectives Know the common age- and season-specific causes of pharyngitis
More informationIn the setting of measles elimination in the United States, the current measles case definition lacks specificity.
12-ID-07 Committee: Infectious Disease Title: Public Health Reporting and ational otification for Measles I. Statement of the Problem In the setting of measles elimination in the United States, the current
More informationCerebral Toxoplasmosis in HIV-Infected Patients. Ahmed Saad,MD,FACP
Cerebral Toxoplasmosis in HIV-Infected Patients Ahmed Saad,MD,FACP Introduction Toxoplasmosis: Caused by the intracellular protozoan, Toxoplasma gondii. Immunocompetent persons with primary infection
More informationORIGINAL CONTRIBUTION. Laura Kupila, MD; Raija Vainionpää, PhD; Tytti Vuorinen, MD, PhD; Reijo J Marttila, MD, PhD; Pirkko Kotilainen, MD, PhD
ORIGINAL CONTRIBUTION Recurrent Lymphocytic Meningitis The Role of Herpesviruses Laura Kupila, MD; Raija Vainionpää, PhD; Tytti Vuorinen, MD, PhD; Reijo J Marttila, MD, PhD; Pirkko Kotilainen, MD, PhD
More informationCouncil of State and Territorial Epidemiologists Position Statement
04-ID-01 Committee: Title: Infectious Disease Revision of the National Surveillance Case Definition of Diseases Caused by Neurotropic Domestic Arboviruses, Including the Addition to the NNDSS of Non-Neuroinvasive
More informationLab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) MIC AMAL ALGHAMDI 1
Lab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) 2018 450 MIC AMAL ALGHAMDI 1 Learning Outcomes The pathogenesis of viral infection The viral disease pattern Specific
More informationAcute neurological syndromes
Acute neurological syndromes Assoc.Prof. Murat Sayan Kocaeli Üniversitesi, Rutin PCR Lab. Sorumlu Öğt.Üyesi Yakın Doğu Üniversitesi, DESAM Kurucu Öğrt. Üyesi sayanmurat@hotmail.com 0533 6479020 Medical
More informationChoosing an appropriate antimicrobial agent. 3) the spectrum of potential pathogens
Choosing an appropriate antimicrobial agent Consider: 1) the host 2) the site of infection 3) the spectrum of potential pathogens 4) the likelihood that these pathogens are resistant to antimicrobial agents
More informationEuropean Guidelines on Management of Tick Borne Encephalitis: a Focus on Intensive Care
European Guidelines on Management of Tick Borne Encephalitis: a Focus on Intensive Care Pille Taba MD, PhD University of Tartu, Estonia Tallinn, 12 September 2014 Why tick borne encephalitis (TBE) guidelines?
More informationSeema Sikka, MD January 18, 2014 TRANSVERSE MYELITIS: A CLINICAL OVERVIEW
Seema Sikka, MD January 18, 2014 TRANSVERSE MYELITIS: A CLINICAL OVERVIEW DISCLOSURES I have no industry relationships to disclose. I will not discuss off-label use. OBJECTIVES: TRANSVERSE MYELITIS Review
More informationAutoimmune Encephalitis
Evaluation Approach for Suspected Autoimmune Encephalitis M.R ASHRAFI PROFESSOR OF PEDIATRIC NEUROLOGY CHILDREN S MEDICAL CENTER PEDIATRIC CENTER OF EXCELLENCE TEHRAN UNIVERSITY OF MEDICAL SCIENCES TEHRAN
More informationinfections, mainly with pneumonia, observed from They comprised two
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 56 (1983), 493-503 M. pneumoniae Respiratory Diseases: Clinical Features -Children YASUTAKA NIITU, M.D. Department of Pediatrics, The Research Institute for Tuberculosis
More informationEncephalitis. HSV Encephalitis. Encephalitis. Viral CNS Infection. WNV Encephalitis GRAY MATTER. Zoran Rumboldt
Encephalitis Viral CNS Infection Hematogenous dissemination ( along peripheral nerves ) Zoran Rumboldt University of Rijeka Medical University of South Carolina Telemedicine Clinic MarinMed Clinic Many
More informationJudith A. Aberg, MD; Linda M. Mundy, MD; and William G. Powderly, MD
Pulmonary Cryptococcosis in Patients Without HIV Infection* Judith A. Aberg, MD; Linda M. Mundy, MD; and William G. Powderly, MD Purpose: To further elucidate the diagnostic and therapeutic approaches
More informationBrain abscess rupturing into the lateral ventricle causing meningitis: a case report
Brain abscess rupturing into the lateral ventricle causing meningitis: a case report Endry Martinez, and Judith Berger SBH Health System, 4422 Third Ave, Bronx, NY 10457 Key words: brain abscess, rupture
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationVIRAL ENCEPHALITIS EASY TO MISS
TAMORISH KOLE MBBS MRCS(EDIN) FRSM(UK) SENIOR CONSULTANT & HEAD, EMERGENCY MEDICINE, MAX HEALTHCARE, NEW DELHI, INDIA ADJUNCT ASSISTANT PROFESSOR, EMERGENCY MEDICINE, GEORGE WASHINGTON UNIVERSITY, WASHINGTON
More informationFaculty Disclosure. Stephen I. Pelton, MD. Dr. Pelton has listed no financial interest/arrangement that would be considered a conflict of interest.
Faculty Disclosure Stephen I. Pelton, MD Dr. Pelton has listed no financial interest/arrangement that would be considered a conflict of interest. Advances in the management of fever in infants 0 to 3 and
More informationNFECTIONS THROUGH THE RESPIRATORY TRACT
NFECTIONS THROUGH THE RESPIRATORY TRACT **Infective agent s **Transmission **Host * viral infections * Bacterial infections *Fungal infections **Control of air-borne infections **INFECTIVE AGENTS The infective
More informationHealth Board Logo. Post SARS Outbreak Surveillance. Report of possible or probable cases (Form version 1) February 11 th 2004
Post SARS Outbreak Surveillance Report of possible or probable cases (Form version 1) February 11 th 2004 This form is to be used for persons who fit the surveillance case definition of possible or probable
More informationPublic Health Image Library. CDC/ Cynthia Goldsmith. Image #
Zika Virus Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar,
More informationHaemophilus influenzae, Invasive Disease rev Jan 2018
Haemophilus influenzae, Invasive Disease rev Jan 2018 BASIC EPIDEMIOLOGY Infectious Agent Haemophilus influenzae (H. influenzae) is a small, Gram-negative bacillus, a bacterium capable of causing a range
More informationMultiple Sclerosis vs Acute Disseminated Encephalomyelitis in Childhood
Multiple Sclerosis vs Acute Disseminated Encephalomyelitis in Childhood Steven David Brass, MD, Zografos Caramanos, BA, Carlos Santos, MD, Marie-Emmanuelle Dilenge, MD, Yves Lapierre, MD, and Bernard Rosenblatt,
More informationThe McMaster at night Pediatric Curriculum
The McMaster at night Pediatric Curriculum Community Acquired Pneumonia Based on CPS Practice Point Pneumonia in healthy Canadian children and youth and the British Thoracic Society Guidelines on CAP Objectives
More informationClinical Infectious Diseases Advance Access published April 11, What is the real role of respiratory viruses in severe community-acquired
Clinical Infectious Diseases Advance Access published April 11, 2014 1 What is the real role of respiratory viruses in severe community-acquired pneumonia? Olli Ruuskanen 1 and Asko Järvinen 2 1 Department
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Blum CA, Nigro N, Briel M, et al. Adjunct prednisone
More information